Microbiology and clinical characteristics of viridans group streptococci in patients with cancer
Open Access
- 17 July 2018
- journal article
- research article
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 22 (4) , 323-327
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Viridans Group Streptococci Clinical Isolates: MALDI-TOF Mass Spectrometry versus Gene Sequence-Based IdentificationPLOS ONE, 2015
- Identification of the ‘Streptococcus anginosus group’ by matrix-assisted laser desorption ionization – time-of-flight mass spectrometryJournal of Medical Microbiology, 2014
- Streptococcus mitis Strains Causing Severe Clinical Disease in Cancer PatientsEmerging Infectious Diseases, 2014
- Editorial Commentary: Viridans Group Streptococci in Febrile Neutropenic Cancer Patients: What Should We Fear?Clinical Infectious Diseases, 2014
- Aetiology of Bacteraemia as a Risk Factor for Septic Shock at the Onset of Febrile Neutropaenia in Adult Cancer PatientsBioMed Research International, 2014
- Value of matrix-assisted laser desorption ionization-time of flight for routine identification of viridans group streptococci causing bloodstream infectionsClinical Microbiology and Infection, 2013
- Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patientsClinical Microbiology and Infection, 2013
- Defining Bloodstream Infections Related to Central Venous Catheters in Patients With Cancer: A Systematic ReviewClinical Infectious Diseases, 2011
- Viridans Streptococci Isolated by Culture from Blood of Cancer Patients: Clinical and Microbiologic Analysis of 50 CasesJournal of Clinical Microbiology, 2006
- Infections Caused by Viridans Streptococci in Patients with NeutropeniaClinical Infectious Diseases, 2002